stoxline Quote Chart Rank Option Currency Glossary
  
Zoetis Inc. (ZTS)
151.94  -1.08 (-0.71%)    04-17 16:00
Open: 153.01
High: 153.18
Volume: 3,258,746
  
Pre. Close: 153.02
Low: 151.24
Market Cap: 69,568(M)
Technical analysis
2024-04-17 4:50:45 PM
Short term     
Mid term     
Targets 6-month :  198.32 1-year :  213.7
Resists First :  169.79 Second :  182.97
Pivot price 161.83
Supports First :  148.47 Second :  123.53
MAs MA(5) :  153.48 MA(20) :  163.46
MA(100) :  184.13 MA(250) :  179.07
MACD MACD :  -7 Signal :  -6.1
%K %D K(14,3) :  13.6 D(3) :  10.7
RSI RSI(14): 27.3
52-week High :  201.91 Low :  148.47
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ZTS ] has closed above bottom band by 13.1%. Bollinger Bands are 47.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 153.61 - 154.46 154.46 - 155.16
Low: 148.57 - 149.79 149.79 - 150.79
Close: 150.15 - 151.96 151.96 - 153.42
Company Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Headline News

Wed, 17 Apr 2024
Zoetis Inc. (NYSE:ZTS) Shares Purchased by Oakworth Capital Inc. - MarketBeat

Wed, 17 Apr 2024
Zoetis (NYSE:ZTS) Stock Price Up 2.2% - MarketBeat

Wed, 17 Apr 2024
Zoetis Inc's Dividend Analysis - Yahoo Finance

Wed, 17 Apr 2024
Zoetis (NYSE:ZTS) Receives Overweight Rating from Piper Sandler - Defense World

Tue, 16 Apr 2024
Zoetis (ZTS) Tops Q1 Earnings Estimates - AOL

Mon, 15 Apr 2024
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc. (ZTS) - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 457 (M)
Shares Float 457 (M)
Held by Insiders 0.2 (%)
Held by Institutions 95.5 (%)
Shares Short 3,650 (K)
Shares Short P.Month 3,770 (K)
Stock Financials
EPS 5.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.89
Profit Margin 27.4 %
Operating Margin 32.1 %
Return on Assets (ttm) 13.1 %
Return on Equity (ttm) 49.8 %
Qtrly Rev. Growth 8.5 %
Gross Profit (p.s.) 0
Sales Per Share 18.68
EBITDA (p.s.) 7.63
Qtrly Earnings Growth 16.3 %
Operating Cash Flow 2,350 (M)
Levered Free Cash Flow 1,280 (M)
Stock Valuations
PE Ratio 29.96
PEG Ratio 2.8
Price to Book value 13.93
Price to Sales 8.12
Price to Cash Flow 29.54
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android